Transinsight Wins FutureSAX VC-Forum for Best Company

TransinsightFutureSAX invited venture capitalists and entrepreneurs from all over Germany to Dresden under the motto "Lift Off with Venture Capital - Emphasis on Technology and Environment." In front of 80 guests, among them 30 investors, the jury selected Transinsight with its software technology for knowledge-based information searches from seven finalists as the winner of the most promising investment.

"The jury choose the Transinsight team because of their excellent business concept and investment, as well as their convincing presentation", says futureSAX representative Kerstin Trautmann. She goes on to say: "the Businessplan-Wettbewerb Sachsen GmbH congratulates the winner for this outstanding success."

"We are proud our concept is regarded as outstanding by top-class investors", says Dr. Michael R. Alvers, CEO of Transinsight GmbH. He continues: "We created software with the potential to revolutionize information searching. Themed "Together we Search, Think, and Write", we raise searching to a new level. We do not rank search results, the user does! This fosters democracy and allows companies and others to save plenty of time, which then becomes available for other relevant tasks."

Mark Miller, CEO of CatCap and a member of the jury, is convinced that close cooperation between the university and new high-tech companies in Dresden will lead to success. "Transinsight GmbH, with its brand new search paradigm, is well-positioned in the rapidly growing information handling and knowledge management market," says Miller.

Related news articles:

About Transinsight
Founded in 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge-based technologies. The flagship product, www.gopubmed.com, a well established biomedical search engine, is the first knowledge-based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technical University Dresden. For further information, visit www.transinsight.com.

About the VC Forum futureSAX
FutureSAX hosted a venture capital forum near the Frauenkirche for intensive discourse between venture capital investors. This forum has been the only VC networking forum to date in Saxony. Companies in the fields of technology and environment from all over Germany looking for investors could apply for one of eight presentation slots. FutureSAX was supported by KPMG and 3i Deutschland GmbH as well as by cooperation partners CatCap GmbH, Neuhaus Partners GmbH, and F.A.Z.-Institut GmbH. Investors were given the chance to get to know different outstanding companies during a single day as well as to get in contact with many potential co-investors. Companies were given the opportunity to present themselves in front of a community of investors. After the presentations, companies and investors got together over refreshments for one-on-one discussions. For further information, visit www.futuresax.de.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...